Clinical Trial Update: FAITH - Factor XA Inhibitor-Related InTracranial Haemorrhage

View source ↗

Summary

The FAITH trial evaluating Factor Xa inhibitor-related intracranial hemorrhage has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intracranial Hemorrhage

Snippet

Sponsor: AstraZeneca | Conditions: InTracranial Haemorrhage | Status: COMPLETED